BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Ovaleap 450units/0.75ml solution for injection cartridges 0605010I0BDABAS	Ovaleap	Follitropin alfa	Endocrine System	No data available
Ovaleap 900units/1.5ml solution for injection cartridges 0605010I0BDACAT	Ovaleap	Follitropin alfa	Endocrine System	No data available
Ovelle aqueous cream 130201100BBBDAM	Proprietary compound preparation BNF 1302011	Emollient bath and shower preparations	Skin	No data available
Ovelle Petroleum jelly white 1302010N0BHAAAA	Ovelle Petroleum jelly	Paraffin soft white	Skin	No data available
Ovelle zinc and castor oil ointment 1302020E0BJAAAC	Ovelle zinc and castor oil	Zinc oxide	Skin	No data available
Ovesse 1mg/g vaginal cream with applicator 0702010F0BGAAAA	Ovesse	Estriol	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Ovestin 1mg tablets 0604011M0BBABAB	Ovestin (Systemic)	Estriol	Endocrine System	No data available
Ovestin 1mg/g vaginal cream with applic (Imported (Germany)) 0702010F0BCABAA	Ovestin (Vaginal)	Estriol	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Ovitrelle 250microgram inj vials 0605010X0BBAAAA	Ovitrelle	Choriogonadotropin alfa	Endocrine System	No data available
Ovran tablets 0703010H0BHAAAE	Ovran	Combined ethinylestradiol 50mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Ovysmen 500microgram/35microgram tablets 0703010G0BBAAAA	Ovysmen	Combined ethinylestradiol 35mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Oxaliplatin 100mg powder for solution for infusion vials 0801050ALAAADAD	Oxaliplatin	Oxaliplatin	Malignant Disease and Immunosuppression	No data available
Oxaliplatin 100mg/20ml solution for infusion vials 0801050ALAAABAB	Oxaliplatin	Oxaliplatin	Malignant Disease and Immunosuppression	No data available
Oxaliplatin 150mg powder for solution for infusion vials 0801050ALAAAFAF	Oxaliplatin	Oxaliplatin	Malignant Disease and Immunosuppression	No data available
Oxaliplatin 200mg/40ml solution for infusion vials 0801050ALAAAEAE	Oxaliplatin	Oxaliplatin	Malignant Disease and Immunosuppression	No data available
Oxaliplatin 50mg powder for solution for infusion vials 0801050ALAAACAC	Oxaliplatin	Oxaliplatin	Malignant Disease and Immunosuppression	No data available
Oxaliplatin 50mg/10ml solution for infusion vials 0801050ALAAAAAA	Oxaliplatin	Oxaliplatin	Malignant Disease and Immunosuppression	No data available
Oxandosin XL 4mg tablets 0205040D0BHAAAQ	Oxandosin	Doxazosin mesilate	Cardiovascular System	No data available
Oxandrin 2.5mg tablets 0604030P0BCAAAB	Oxandrin	Oxandrolone	Endocrine System	No data available
Oxazepam 12.5mg/5ml oral suspension 0401020T0AAAIAI	Oxazepam	Oxazepam	Central Nervous System	No data available
Oxazepam 2.5mg/5ml oral suspension 0401020T0AAAHAH	Oxazepam	Oxazepam	Central Nervous System	No data available
Oxazepam 2mg/5ml oral suspension 0401020T0AAAKAK	Oxazepam	Oxazepam	Central Nervous System	No data available
OxBipp paste 131005000BBBXAE	Proprietary compound preparation BNF 1310050	Other minor cut and abrasion preparations	Skin	No data available
Oxcarbazepine 400mg/5ml oral suspension 0408010D0AAAFAF	Oxcarbazepine	Oxcarbazepine	Central Nervous System	No data available
Oximag 100mg capsules 0101010I0BGAAAB	Oximag	Magnesium oxide	Gastro-Intestinal System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.